The “lows”: Update on ER-low and HER2-low breast cancer

ER-low and HER2-low breast cancers have emerged as clinically significant subtypes that challenge traditional diagnostic categories and treatment paradigms. These subtypes, representing a spectrum of disease, exhibit distinct biological behaviors, therapeutic responses, and prognostic outcomes. HER2...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicola Fusco, Giuseppe Viale
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977624001620
Tags: Add Tag
No Tags, Be the first to tag this record!